These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 12124237)
1. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Bradley KM; Bydder GM; Budge MM; Hajnal JV; White SJ; Ripley BD; Smith AD Br J Radiol; 2002 Jun; 75(894):506-13. PubMed ID: 12124237 [TBL] [Abstract][Full Text] [Related]
2. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Schott JM; Price SL; Frost C; Whitwell JL; Rossor MN; Fox NC Neurology; 2005 Jul; 65(1):119-24. PubMed ID: 16009896 [TBL] [Abstract][Full Text] [Related]
3. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials. Schott JM; Frost C; Whitwell JL; Macmanus DG; Boyes RG; Rossor MN; Fox NC J Neurol; 2006 Sep; 253(9):1147-53. PubMed ID: 16998650 [TBL] [Abstract][Full Text] [Related]
4. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
5. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Fox NC; Cousens S; Scahill R; Harvey RJ; Rossor MN Arch Neurol; 2000 Mar; 57(3):339-44. PubMed ID: 10714659 [TBL] [Abstract][Full Text] [Related]
6. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI. Preboske GM; Gunter JL; Ward CP; Jack CR Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273 [TBL] [Abstract][Full Text] [Related]
7. Mapping hippocampal and ventricular change in Alzheimer disease. Thompson PM; Hayashi KM; De Zubicaray GI; Janke AL; Rose SE; Semple J; Hong MS; Herman DH; Gravano D; Doddrell DM; Toga AW Neuroimage; 2004 Aug; 22(4):1754-66. PubMed ID: 15275931 [TBL] [Abstract][Full Text] [Related]
8. Morphometric measurements of MRI findings in patients with Alzheimer's disease. Yücel F; Yaman SO; Ozbabalık D; Ozkan S; Ortuğ G; Ozdemіr G Adv Clin Exp Med; 2014; 23(1):91-6. PubMed ID: 24596009 [TBL] [Abstract][Full Text] [Related]
9. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. Fox NC; Freeborough PA J Magn Reson Imaging; 1997; 7(6):1069-75. PubMed ID: 9400851 [TBL] [Abstract][Full Text] [Related]
10. Trajectories of brain loss in aging and the development of cognitive impairment. Carlson NE; Moore MM; Dame A; Howieson D; Silbert LC; Quinn JF; Kaye JA Neurology; 2008 Mar; 70(11):828-33. PubMed ID: 18046010 [TBL] [Abstract][Full Text] [Related]
11. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314 [TBL] [Abstract][Full Text] [Related]
12. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578 [TBL] [Abstract][Full Text] [Related]
13. Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease. Spulber G; Niskanen E; MacDonald S; Smilovici O; Chen K; Reiman EM; Jauhiainen AM; Hallikainen M; Tervo S; Wahlund LO; Vanninen R; Kivipelto M; Soininen H Neurobiol Aging; 2010 Sep; 31(9):1601-5. PubMed ID: 18829136 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of whole brain health in aging and Alzheimer's disease: a standard procedure for scoring an MRI-based brain atrophy and lesion index. Guo H; Song X; Schmidt MH; Vandorpe R; Yang Z; LeBlanc E; Zhang J; Beyea S; Zhang Y; Rockwood K J Alzheimers Dis; 2014; 42(2):691-703. PubMed ID: 24927702 [TBL] [Abstract][Full Text] [Related]
15. [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia]. Förstl H; Besthorn C; Sattel H; Zerfass R; Geiger-Kabisch C; Schreiter-Gasser U; Hentschel F Nervenarzt; 1996 Jan; 67(1):53-61. PubMed ID: 8676989 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
17. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Ridha BH; Barnes J; van de Pol LA; Schott JM; Boyes RG; Siddique MM; Rossor MN; Scheltens P; Fox NC Arch Neurol; 2007 Jun; 64(6):849-54. PubMed ID: 17562933 [TBL] [Abstract][Full Text] [Related]
18. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations. Nakamura K; Brown RA; Narayanan S; Collins DL; Arnold DL; Neuroimage; 2015 Sep; 118():126-32. PubMed ID: 26049148 [TBL] [Abstract][Full Text] [Related]
19. Boosting diagnosis accuracy of Alzheimer's disease using high dimensional recognition of longitudinal brain atrophy patterns. Farzan A; Mashohor S; Ramli AR; Mahmud R Behav Brain Res; 2015 Sep; 290():124-30. PubMed ID: 25889456 [TBL] [Abstract][Full Text] [Related]